Familial hyperaldosteronism type II (FH-II), was first described by Gordon et al as a second form of autosomal dominant form of PA, not remediable with glucocorticoids and not due to the presence of the chimeric CYP11B1/CYP11B2 gene [97]. The gene discussed is CYP11B2; the disease is familial hyperaldosteronism type II.